| Net Cash Provided by (Used in) Operating Activities |
-922K |
USD |
-381% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
-79.5K |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
662K |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
25M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
15.8M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-339K |
USD |
-227% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.83M |
USD |
-34.5% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
383K |
USD |
+26.4% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
1.91M |
USD |
+22.5% |
Q1 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
52.2K |
USD |
+58.5% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
10.2M |
USD |
+4.82% |
Q1 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
-143K |
USD |
-0.4% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
10.2M |
USD |
+3.01% |
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
154K |
USD |
-3.01% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.53M |
USD |
+21.5% |
Q1 2025 |
FY 2025 |